Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Omvoh
Pharma
Lilly says it's setting 'higher bar' in IBD with Omvoh post-hoc
The new findings tied Omvoh to patients meeting multiple simultaneous treatment goals in ulcerative colitis and Crohn’s at one year.
Fraiser Kansteiner
Oct 15, 2026 11:00am
New IL-23 UC drugs 'rapidly gained significant momentum': report
Nov 18, 2024 8:55am
Lilly shows restroom rarity affects ulcerative colitis patients
Oct 17, 2024 10:55am
Lilly's Omvoh bests J&J's Stelara in Crohn's study
Oct 14, 2024 12:15pm
AbbVie’s Skyrizi passes Lilly’s Omvoh to take lead in colitis
Oct 7, 2024 10:53am
Lilly pads case for mirikizumab in its next potential indication
May 21, 2024 9:20am
